Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.97 -0.10 (-3.26%)
As of: Oct 21, 2026 · 11:22 AM EDT

Galmed Pharmaceuticals (EOCN) Net Margin (2016 - 2023)

Updated

Galmed Pharmaceuticals' Net Margin was 483.61% in FY2018, down 649.94 percentage points from 1133.55% in FY2017.

Analysis

Galmed Pharmaceuticals (EOCN) Net Margin (2016 - 2023) Analysis & Trends

  • Per Business Quant data, Net Margin in earlier years was 1133.55% in FY2017 (-2496.64 pp) and 3630.19% in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 21.86%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 21.27%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -8.04%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 16.30%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -134.51%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -1.65%
10 Galmed Pharmaceuticals 1.60 Mn -39.09 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -915.00%
Mar 31, 2022 -6,825.56%
Sep 30, 2018 63.93%
Jun 30, 2018 994.44%
Mar 31, 2018 935.07%
Dec 31, 2017 1,329.93%
Sep 30, 2017 1,026.01%
Jun 30, 2017 997.04%
Mar 31, 2017 1,179.85%
Dec 31, 2016 1,761.31%
Sep 30, 2016 1,985.49%
API Access

Galmed Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=EOCN&period=max&api_key=YOUR_API_KEY